IPO FILING - <ORGANIZATION>Transkaryotic Therapies Inc .</ORGANIZATION>
WASHINGTON 1996-08-27
Company Name Transkaryotic Therapies Inc
Nasdaq Stock symbol TKTX
Estimated price range <CURRENCY>$ 13</CURRENCY> - <CURRENCY>$ 15</CURRENCY> / shr
Total shares to be offered 2.5 million
Shrs offered by company 2.5 million
Shrs outstanding after ipo 16,668,560
<ORGANIZATION>Lead Underwriter Morgan Stanley and Co Inc</ORGANIZATION>
Underwriters over-allotment 375,000 shrs Shares to be purchased by <ORGANIZATION>Hoechst Marion Roussel Inc</ORGANIZATION> 357,143 Business : developed two proprietary technology platforms , gene activation and gene therapy .
Use of Proceeds : Research , preclinical and clinical product development , and general corporate purposes .
Financial Data in 000s : 1995 1994
- Revenue <CURRENCY>$ 15,400 $ 10,000</CURRENCY>
- Net Income ( loss ) <CURRENCY>$ 2,074 ( $ 3,422</CURRENCY> )

